We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.8% |
| 3 | Industrials | 15.3% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Honeywell
HON
$66.7B
| $544M | 0.56% |
5,404,490
-21,045
| -0.4% | -$1.97M |
2013 Q2
11 quarters
|
|
|
ABMD
52
DELISTED
Abiomed Inc
ABMD
| $525M | 0.54% |
5,535,290
-121,800
| -2% | -$10.3M |
2013 Q2
11 quarters
|
|
53
Royal Caribbean
RCL
$74.9B
| $482M | 0.5% |
5,869,872
+792,071
| +16% | +$61.8M |
2013 Q2
11 quarters
|
|
|
SGEN
54
DELISTED
Seagen Inc. Common Stock
SGEN
| $477M | 0.49% |
13,589,187
+707,012
| +5% | +$23.7M |
2013 Q2
11 quarters
|
|
55
Caterpillar
CAT
$338B
| $476M | 0.49% |
6,219,249
+135,248
| +2% | +$9.07M |
2013 Q2
11 quarters
|
|
|
QGENF
56
DELISTED
QIAGEN NV
QGENF
| $458M | 0.47% |
20,493,375
-38,950
| -0.2% | -$870K |
2013 Q2
11 quarters
|
|
57
JetBlue
JBLU
$1.19B
| $425M | 0.44% |
20,142,714
+35,200
| +0.2% | +$740K |
2013 Q2
11 quarters
|
|
58
Progressive
PGR
$124B
| $413M | 0.43% |
11,766,525
+86,200
| +0.7% | +$2.76M |
2014 Q3
6 quarters
|
|
59
United Parcel Service
UPS
$83.2B
| $409M | 0.42% |
3,880,998
+8,000
| +0.2% | +$777K |
2013 Q2
11 quarters
|
|
60
Deere & Co
DE
$175B
| $407M | 0.42% |
5,286,519
+856,000
| +19% | +$67M |
2013 Q2
11 quarters
|
|
61
Corning
GLW
$119B
| $405M | 0.42% |
19,378,500
+31,800
| +0.2% | +$590K |
2013 Q2
11 quarters
|
|
62
Union Pacific
UNP
$172B
| $373M | 0.39% |
4,693,100
-7,300
| -0.2% | -$564K |
2013 Q2
11 quarters
|
|
|
63
AstraZeneca
AZN
$259B
| $368M | 0.38% |
6,542,138
+6,047,688
| +1,223% | +$363M |
2015 Q3
2 quarters
|
|
64
CVS Health
CVS
$118B
| $368M | 0.38% |
3,548,780
+3,710
| +0.1% | +$361K |
2013 Q2
11 quarters
|
|
65
Jacobs Solutions
J
$16.6B
| $356M | 0.37% |
9,875,840
+407,151
| +4% | +$13.3M |
2013 Q2
11 quarters
|
|
66
Illumina
ILMN
$40.5B
| $353M | 0.37% |
2,235,664
+607
| +0% | +$92.8K |
2013 Q2
11 quarters
|
|
|
ELLI
67
DELISTED
Ellie Mae Inc
ELLI
| $350M | 0.36% |
3,861,950
-22,600
| -0.6% | -$1.69M |
2013 Q2
11 quarters
|
|
|
ATVI
68
DELISTED
Activision Blizzard
ATVI
| $350M | 0.36% |
10,334,800
+21,450
| +0.2% | +$703K |
2013 Q2
11 quarters
|
|
69
Trimble
TRMB
$14.2B
| $330M | 0.34% |
13,319,816
+230,400
| +2% | +$5.09M |
2013 Q2
11 quarters
|
|
70
SLB Ltd
SLB
$71.8B
| $328M | 0.34% |
4,443,971
-4,353
| -0.1% | -$306K |
2013 Q2
11 quarters
|
|
|
71
Johnson & Johnson
JNJ
$610B
| $327M | 0.34% |
3,023,678
-7,519,884
| -71% | -$779M |
2013 Q2
11 quarters
|
|
72
Oracle
ORCL
$408B
| $317M | 0.33% |
7,751,850
-939,275
| -11% | -$34.8M |
2013 Q2
11 quarters
|
|
|
DWA
73
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
| $292M | 0.3% |
11,696,200
| – | – |
2013 Q2
11 quarters
|
|
|
ETFC
74
DELISTED
E*Trade Financial Corporation
ETFC
| $278M | 0.29% |
11,343,300
+5,087,900
| +81% | +$123M |
2014 Q4
5 quarters
|
|
75
Nektar Therapeutics
NKTR
$1.29B
| $275M | 0.29% |
1,334,006
+15,054
| +1% | +$2.89M |
2013 Q2
11 quarters
|
|
Similar funds
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.